Supplement
Tetradecyl thioacetic acid is a modified fatty acid with a sulfur atom in its chain, which the body cannot burn for fuel like ordinary fats and which switches on fat-handling genes instead. In people with high cholesterol, small studies found apolipoprotein B improved and cell adhesion factors went down, though the evidence is limited. Those trials enrolled only 10 to 43 people, and blood glucose showed no clear difference in 18 people.
- Updated
- How we grade
- 4 studies cited
- Best evidence
- Grade C
- Conditions studied
- 8
- Outcomes
- 97
- Graded outcomes
- 0054
Evidence by condition
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Apolipoprotein B Small Improvement | Improves (the measure goes down) | Small effect | 10 people | |||
| Cell Adhesion Factors Small Decrease | Improves (the measure goes down) | Small effect | 43 people | |||
| HbA1c | Improves (the measure goes down) | 1 study | 10 people | |||
| Total cholesterol | Improves (the measure goes down) | 1 study | 53 people | |||
Studies that measured total cholesterol | ||||||
| Weight | Improves (the measure goes down) | 1 study | 10 people | |||
| Glycemic Control | Improves (the measure goes up) | 10 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 10 people | ||||
| HIV Viral Load | Improves (the measure goes up) | 10 people | ||||
| Kidney Function | Improves (the measure goes up) | 10 people | ||||
| Liver Enzymes | Changes; see studies | 10 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 10 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 53 people | ||||
| Triglycerides | Improves (the measure goes down) | 53 people | ||||
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cell Adhesion Factors Small Decrease | Improves (the measure goes down) | Small effect | 43 people | |||
| Total cholesterol | Improves (the measure goes down) | 1 study | 43 people | |||
Studies that measured total cholesterol | ||||||
| TNF-Alpha | Improves (the measure goes down) | 43 people | ||||
| Triglycerides | Improves (the measure goes down) | 43 people | ||||
Type 2 Diabetes
- Blood Pressure: improves
- HbA1c: improves
- Weight: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood Pressure Small Improvement | Improves (the measure goes down) | Small effect | 16 people | |||
| HbA1c | Improves (the measure goes down) | 1 study | 16 people | |||
| Weight | Improves (the measure goes down) | 1 study | 16 people | |||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 16 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 16 people | ||||
| Liver Enzymes | Changes; see studies | 16 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 16 people | ||||
| Uric Acid | Improves (the measure goes down) | 16 people | ||||
Human Immunodeficiency Virus (HIV)
- Apolipoprotein B: improves
- HbA1c: improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Apolipoprotein B Small Improvement | Improves (the measure goes down) | Small effect | 10 people | |||
| HbA1c | Improves (the measure goes down) | 1 study | 10 people | |||
| Total cholesterol | Improves (the measure goes down) | 1 study | 10 people | |||
Studies that measured total cholesterol | ||||||
| Weight | Improves (the measure goes down) | 1 study | 10 people | |||
| Glycemic Control | Improves (the measure goes up) | 10 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 10 people | ||||
| HIV Viral Load | Improves (the measure goes up) | 10 people | ||||
| Kidney Function | Improves (the measure goes up) | 10 people | ||||
| Liver Enzymes | Changes; see studies | 10 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 10 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 10 people | ||||
| Triglycerides | Improves (the measure goes down) | 10 people | ||||
General Cardiovascular Health
- Blood glucose
- HbA1c: improves
- Heart Rate: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 18 people | ||||
| HbA1c | Improves (the measure goes down) | 1 study | 16 people | |||
| Heart Rate | Improves (the measure goes down) | 1 study | 18 people | |||
Studies that measured heart rate | ||||||
| Total cholesterol | Improves (the measure goes down) | 1 study | 18 people | |||
Studies that measured total cholesterol | ||||||
| Weight | Improves (the measure goes down) | 1 study | 16 people | |||
| Blood Pressure | Improves (the measure goes down) | 34 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 34 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 34 people | ||||
| Liver Enzymes | Changes; see studies | 34 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 34 people | ||||
| Red Blood Cell Count | Improves (the measure goes up) | 18 people | ||||
| Serum T4 | Improves (the measure goes up) | 18 people | ||||
| Thyroid-Stimulating Hormone | Improves (the measure goes up) | 18 people | ||||
| Triglycerides | Improves (the measure goes down) | 18 people | ||||
| Uric Acid | Improves (the measure goes down) | 34 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 18 people | ||||
Immune Health
- Blood glucose
- HbA1c: improves
- Heart Rate: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 18 people | ||||
| HbA1c | Improves (the measure goes down) | 1 study | 10 people | |||
| Heart Rate | Improves (the measure goes down) | 1 study | 18 people | |||
Studies that measured heart rate | ||||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 18 people | ||||
| Glycemic Control | Improves (the measure goes up) | 10 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 28 people | ||||
| HIV Viral Load | Improves (the measure goes up) | 10 people | ||||
| Liver Enzymes | Changes; see studies | 28 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 28 people | ||||
| Red Blood Cell Count | Improves (the measure goes up) | 18 people | ||||
| Serum T4 | Improves (the measure goes up) | 18 people | ||||
| Thyroid-Stimulating Hormone | Improves (the measure goes up) | 18 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 10 people | ||||
| Triglycerides | Improves (the measure goes down) | 28 people | ||||
| Uric Acid | Improves (the measure goes down) | 18 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 18 people | ||||
General Liver Health
- Blood glucose
- Heart Rate: improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 18 people | ||||
| Heart Rate | Improves (the measure goes down) | 1 study | 18 people | |||
Studies that measured heart rate | ||||||
| Total cholesterol | Improves (the measure goes down) | 1 study | 18 people | |||
Studies that measured total cholesterol | ||||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 18 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 18 people | ||||
| Kidney Function | Improves (the measure goes up) | 18 people | ||||
| Liver Enzymes | Changes; see studies | 18 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 18 people | ||||
| Red Blood Cell Count | Improves (the measure goes up) | 18 people | ||||
| Serum T4 | Improves (the measure goes up) | 18 people | ||||
| Thyroid-Stimulating Hormone | Improves (the measure goes up) | 18 people | ||||
| Triglycerides | Improves (the measure goes down) | 18 people | ||||
| Uric Acid | Improves (the measure goes down) | 18 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 18 people | ||||
Metabolic Health
- Blood glucose
- Heart Rate: improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose No effect | NoneNo effect | 18 people | ||||
| Heart Rate | Improves (the measure goes down) | 1 study | 18 people | |||
Studies that measured heart rate | ||||||
| Total cholesterol | Improves (the measure goes down) | 1 study | 18 people | |||
Studies that measured total cholesterol | ||||||
| Blood Pressure | Improves (the measure goes down) | 18 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 18 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 18 people | ||||
| Kidney Function | Improves (the measure goes up) | 18 people | ||||
| Liver Enzymes | Changes; see studies | 18 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 18 people | ||||
| Serum T4 | Improves (the measure goes up) | 18 people | ||||
| Thyroid-Stimulating Hormone | Improves (the measure goes up) | 18 people | ||||
| Triglycerides | Improves (the measure goes down) | 18 people | ||||
| Uric Acid | Improves (the measure goes down) | 18 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 18 people | ||||
Key findings
- Apolipoprotein BImproves (the measure goes down)
- Cell Adhesion FactorsImproves (the measure goes down)
- Blood PressureImproves (the measure goes down)
Shop Tetradecyl Thioacetic Acid
Third-party tested Tetradecyl Thioacetic Acid products. The evidence above is limited, so read it before you buy.
- Grade C
Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure
Studies cited
4 studies from PubMed
- Pharmacology and safety of tetradecylthioacetic acid (TTA): phase-1 study
- Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-alpha/delta activation and increased mitochondrial fatty acid oxidation
- Lipid-lowering and anti-inflammatory effects of tetradecylthioacetic acid in HIV-infected patients on highly active antiretroviral therapy
- Anti-inflammatory and hypolipidemic effects of the modified fatty acid tetradecylthioacetic acid in psoriasis--a pilot study